Sangamo Biosciences Short Ratio

The Macroaxis Equity Filters allow users to customize the simple screener criteria below or select from a set of available quick indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Short Ratio Analysis

Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Sangamo Biosciences 
Short Ratio 
Short Interest 
Average Trading Volume 
9.55 times

Distress Driver Correlations

About Short Ratio

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare to competition

Sangamo Biosciences Short Ratio Assessment

Benchmark  Embed   Sangamo Biosciences Comparables 
Based on latest financial disclosure Sangamo Biosciences Inc has Short Ratio of 9.55 times. This is 148.05% higher than that of the Healthcare sector, and 153.99% higher than that of Biotechnology industry, The Short Ratio for all stocks is 356.94% lower than the firm.

Filter other Stocks by Short Ratio

Short Ratio Input Range 
Click to run this filter
Filter Other Equities
Found 8 equities by Short Ratio
GILD NMSGilead Sciences Inc
1.65 times
BIIB NMSBiogen Inc
0.96 times
REGN NMSRegeneron Pharmaceuticals Inc
2.46 times
ALXN NMSAlexion Pharmaceuticals Inc
1.58 times
INCY NMSIncyte Corporation
2.41 times
VRTX NMSVertex Pharmaceuticals Incorporated
3.09 times
ILMN NMSIllumina Inc
2.8 times
SGEN NMSSeattle Genetics Inc
6.59 times
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Peer Comparison
Sangamo Biosciences Short Ratio Comparison
  Short Ratio 
Benchmark  Embed   Sangamo Biosciences Comparables 
Sangamo Biosciences is currently under evaluation in short ratio category among related companies.
Did you try this?
Run Headlines Timeline Now

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Hide  View All  Next  Launch Headlines Timeline
Return On Equity(43.78) %
Return On Asset(22.72) %
Profit Margin(261.81) %
Operating Margin(368.76) %
Current Valuation59.23 M
Shares Outstanding70.62 M
Shares Owned by Insiders4.18 %
Shares Owned by Institutions71.00 %
Number of Shares Shorted8.63 M
Price to Book1.42 times
Price to Sales10.46 times
Revenue19.59 M
Gross Profit39.54 M
EBITDA(71.24 M)
Net Income(76.05 M)
Cash and Equivalents145.58 M
Cash per Share2.06 times
Current Ratio10.73 times
Book Value Per Share2.04 times
Cash Flow from Operations(62.69 M)
Short Ratio9.55 times
One Year High9.55
One Year Low2.65
Earnings Per Share(1.08) times
Number of Employees119
Market Capitalization218.93 M
Total Asset164.98 M
Retained Earnings(431.29 M)
Working Capital119.14 M
Current Asset148.84 M
Current Liabilities13.87 M
Z Score-2.8